Taruscio Domenica, Gentile Amalia E, Evangelista Teresinha, Frazzica Rosa G, Bushby Kate, Montserrat Antoni Moliner
Italian National Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy.
Institute of Genetic Medicine, International Centre for Life, Newcastle upon Tyne, United Kingdom.
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s621-5. doi: 10.2450/2014.0026-14s.
Rare diseases, because of their intrinsic characteristics - large number of disorders and syndromes, low individual prevalence, severity, often limited information, lack of therapies - can benefit from collaboration and sharing of expertise while maximising the limited resources available for these conditions. Therefore, the development of Centres of Expertise (CEs) and European Reference Networks (ERNs) in this field is crucial.The European Union Committee of Experts on Rare Diseases (EUCERD) has been charged to assist the European Commission with the preparation and implementation of activities in the field of rare diseases in Europe. In particular, EUCERD has assisted the EC in drawing up the recommendations issued in the Commission Communication and in the Council Recommendation. In this paper the authors focus on the EUCERD Recommendations on CEs and one on ERNs.
Recommendations on CEs and ERNs are the result of two different processes, developed through iterative reviews and discussions at workshops and EUCERD meetings, and according to the European Union documents.
EUCERD has issued two complementary Recommendations, one on CEs (2011) and a second on ERNs (2013). Both address multiple targets (from Member States to Centres, and patient organisations), with the objective of helping them define and organise CEs and ERNs.
The establishment, designation, financial support, and evaluation of CEs throughout Europe allow RD patients and local health care providers to identify high-quality specialised services that can simplify disease management and improve patients' care. The EUCERD Recommendations are useful instruments to help and guide stakeholders in the development of CEs and ERNs and thus ensure equity of access to services and care for rare diseases patients across Europe.
罕见病因其内在特征——疾病和综合征种类繁多、个体患病率低、病情严重、信息往往有限、缺乏治疗方法——可以通过专业知识的协作与共享,同时最大限度地利用针对这些疾病的有限资源而受益。因此,该领域专业中心(CEs)和欧洲参考网络(ERNs)的发展至关重要。欧洲联盟罕见病专家委员会(EUCERD)负责协助欧盟委员会筹备和开展欧洲罕见病领域的活动。特别是,EUCERD协助欧盟委员会起草了委员会通报和理事会建议中发布的建议。在本文中,作者重点关注EUCERD关于专业中心的建议和关于欧洲参考网络的一项建议。
关于专业中心和欧洲参考网络的建议是两个不同过程的结果,通过研讨会和EUCERD会议上的反复审查和讨论,并根据欧盟文件制定。
EUCERD发布了两项互补的建议,一项关于专业中心(2011年),另一项关于欧洲参考网络(2013年)。两者都针对多个目标(从成员国到中心以及患者组织),目的是帮助它们界定和组织专业中心和欧洲参考网络。
在全欧洲建立、指定、提供财政支持和评估专业中心,使罕见病患者和当地医疗服务提供者能够找到高质量的专业服务,从而简化疾病管理并改善患者护理。EUCERD的建议是有用的工具,可帮助和指导利益相关者发展专业中心和欧洲参考网络,从而确保欧洲各地罕见病患者获得服务和护理的公平性。